Grifols (GIFLF) Free Cash Flow (QoQ) (2010 - 2020)
Powered by 
Analysis
Grifols (GIFLF) Free Cash Flow (QoQ) (2010 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | -69.02% |
| Mar 31, 2019 | -140.86% |
| Jun 30, 2018 | 63.97% |
| Mar 31, 2018 | -83.05% |
| Jun 30, 2017 | 65.53% |
| Mar 31, 2017 | -20.48% |
| Dec 31, 2016 | -15.29% |
| Dec 31, 2015 | 74.54% |
| Sep 30, 2015 | -20.91% |
| Jun 30, 2015 | 539.25% |
| Mar 31, 2015 | -90.45% |
| Dec 31, 2014 | -53.59% |
| Sep 30, 2014 | 609.52% |
| Jun 30, 2014 | -199.79% |
| Mar 31, 2014 | -44.45% |
| Dec 31, 2013 | 172.06% |
| Sep 30, 2013 | -53.85% |
| Jun 30, 2013 | 101.14% |
| Mar 31, 2013 | -40.83% |
| Dec 31, 2012 | 23.34% |